Published on
August 10, 2021
- 08:00 GMT
Proteon Pharmaceuticals Secures 21 million Euro to Accelerate Growth
Proteon Pharmaceuticals secures investment to accelerate commercialization of products and expansion of phage product development platform. WARSAW, POLAND, August 10, 2021 /EINPresswire.com/ -- Proteon Pharmaceuticals today announced an investment of 21 million Euro to accelerate commercialization of its products, which aim to reduce the reliance on antibiotics within aquaculture and livestock farming. Proteon Pharmaceuticals uses bacteriophages to reduce the need for antibiotics, improve on-farm …
Distribution channels:
Agriculture, Farming & Forestry Industry, Banking, Finance & Investment Industry
...